Währungen / MYGN
MYGN: Myriad Genetics Inc
6.37
USD
0.15
(2.41%)
Der Wechselkurs von MYGN hat sich für heute um 2.41% verändert. Im Laufe des Tages wurde das Instrument von einem Tief von 6.21 bis zu einem Hoch von 6.56 gehandelt.
Verfolgen Sie die Myriad Genetics Inc-Dynamik. Mit Echtzeit-Kursen können Sie schnell auf Marktveränderungen reagieren. Indem Sie zwischen verschiedenen Zeitrahmen wechseln, können Sie Kurstrends und -dynamik nach Minuten, Stunden, Tagen, Wochen und Monaten verfolgen. Nutzen Sie diese Informationen, um Marktveränderungen vorherzusagen und fundierte Handelsentscheidungen zu treffen.
- M5
- M15
- M30
- H1
- H4
- D1
- W1
- MN
MYGN News
- Myriad Genetics stock rating reiterated at Neutral by UBS with $6 target
- Myriad Genetics soars 65% following InvestingPro’s May fair value alert
- Myriad: HCT In Oncology Continues To Deliver Increased Volume And Revenue
- U.S. stocks higher at close of trade; Dow Jones Industrial Average up 0.19%
- Shopify, Astera Labs, Myriad Genetics, Grocery Outlet And Other Big Stocks Moving Higher On Wednesday - Astera Labs (NASDAQ:ALAB), Arista Networks (NYSE:ANET)
- Why Astera Labs Shares Are Trading Higher By Over 17%; Here Are 20 Stocks Moving Premarket - Astera Labs (NASDAQ:ALAB), Digital Turbine (NASDAQ:APPS)
- Myriad Genetics, Inc. 2025 Q2 - Results - Earnings Call Presentation (NASDAQ:MYGN)
- Myriad Genetics, Inc. (MYGN) Q2 2025 Earnings Call Transcript
- Myriad Genetics (MYGN) Q2 Revenue Up 6%
- Compared to Estimates, Myriad (MYGN) Q2 Earnings: A Look at Key Metrics
- Myriad Genetics (MYGN) Q2 Earnings and Revenues Surpass Estimates
- Myriad Genetics Q2 2025 slides: revenue growth accelerates, guidance raised
- Myriad Genetics earnings beat by $0.06, revenue topped estimates
- Myriad Genetics secures $200 million credit facility from OrbiMed
- Piper Sandler sees opportunity in dislocated Life Science stocks
- Myriad Genetics at Goldman Sachs Conference: Strategic Growth Amid Challenges
- Myriad Genetics Announces Early Access to the FirstGene Multiple Prenatal Screen
- Myriad Genetics Shares New Clinical Data Demonstrating Sensitivity of Precise MRD Across Multiple Cancer Types
- Myriad Genetics Highlights New Research Advancements and Oncology Innovations at 2025 ASCO Annual Meeting
- Scotiabank cuts Myriad Genetics stock rating, slashes price target
- This UnitedHealth Group Analyst Turns Bearish; Here Are Top 3 Downgrades For Wednesday - Pennant Park Investment (NYSE:PNNT), Myriad Genetics (NASDAQ:MYGN)
- CI&T, Novavax, Paramount Group And Other Big Stocks Moving Higher On Monday - Avino Silver & Gold Mines (AMEX:ASM), BGC Group (NASDAQ:BGC)
- Updated: Myriad Genetics to Participate in Two Upcoming Investor Healthcare Conferences
- Crude Oil Falls 1%; Uber Sales Miss Estimates - CuriosityStream (NASDAQ:CURI), Asset Entities (NASDAQ:ASST)
Tagesspanne
6.21
6.56
Jahresspanne
3.76
29.30
- Vorheriger Schlusskurs
- 6.22
- Eröffnung
- 6.25
- Bid
- 6.37
- Ask
- 6.67
- Tief
- 6.21
- Hoch
- 6.56
- Volumen
- 2.170 K
- Tagesänderung
- 2.41%
- Monatsänderung
- 69.41%
- 6-Monatsänderung
- -41.02%
- Jahresänderung
- -77.48%
31 August, Sonntag